Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Valentine CurtisChief Financial Officer | Open-market sale | SELL | $16K 206 sh | Mar 16, 2026 |
| 36 | Coffin KimSVP, Chief Forager | Open-market sale | SELL | $17K 209 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 36 | Hamilton DustinChief Stores Officer | Open-market sale | SELL | $26K 330 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 35 | Hopman MarkChief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $25K 856 sh | Mar 16, 2026 traded Dec 2, 2025 |
| 35 | Marchetti Kevin PatrickDirector, Co-Executive Chairman, 10% Owner | Open-market purchase | BUY | $499K 13.3K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 35 | Moriarty Brian AndrewSVP - Corporate Communications | Open-market sale | SELL | $282K 5,000 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 35 | Chuang Patrick T.Senior VP, Memory Design | Open-market sale | SELL | $342K 40.0K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 34 | Lentell EricChief Legal & Strategy Officer | Open-market sale | SELL | $51K 8,059 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 34 | Hopman MarkChief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $63K 2,061 sh | Mar 16, 2026 traded Dec 4, 2025 |
| 34 | Montgomery Pamela W.Chief Legal Officer-Healthcare | Open-market purchase | BUY | $7,021 79 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 34 | Rosen TamiDirector, Chief Development Officer | Open-market sale | SELL | $65K 5,905 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 34 | Perros EvangelosChief Financial Officer | Open-market sale | SELL | $93K 8,425 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 34 | Garis Douglas MichaelEVP&CFO | Open-market purchase | BUY | $23K 1,300 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 32 | Do CharlesSr. Vice President, HDFSI | Open-market sale | SELL | $77K 4,241 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 32 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $2.37M 24.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 32 | Armenta AnthonyChief Software & Data Officer | Open-market sale | SELL | $35K 3,567 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 31 | Shah HusnalChief Product Officer | Open-market sale | SELL | $14K 3,651 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 31 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $256K 2,840 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 31 | Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER | Open-market sale | SELL | $20K 4,844 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 31 | Le Pendeven YvesCFO | Open-market sale | SELL | $13K 3,199 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 31 | Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER | Open-market sale | SELL | $23K 6,250 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 31 | Shah HusnalChief Product Officer | Open-market sale | SELL | $9,774 2,358 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 30 | Daggs Nicole JEVP, Human Res & Corp Svcs | Open-market sale · 10b5-1 plan | SELL | $390K 4,189 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 29 | Korch Angela AEVP & Chief Financial Officer | Open-market purchase | BUY | $25K 190 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 29 | Sweet Alan JeffreyDirector | Open-market purchase | BUY | $7,977 215 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 28 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $75K 831 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 28 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $140K 1,554 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 27 | Montgomery Pamela W.Chief Legal Officer-Healthcare | Option exercise | M | — 1,523 sh | Mar 16, 2026 traded Mar 10, 2026 |
| 27 | Walsh Mark T.Director, CEO & Director | Tax withholding | F | $280K 34.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 27 | Le Pendeven YvesCFO | Open-market sale | SELL | $11K 2,832 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 27 | Gupta PriyaInterim CFO | Open-market sale | SELL | $46K 7,263 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 27 | Ehinger John Anthony JrHead of Legal and Compliance | Grant or award | A | — 5,549 sh | Mar 16, 2026 traded Feb 23, 2026 |
| 27 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $753K 93.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 25 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $542K 5,505 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 24 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | $62K 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 24 | Harris RyanEVP Head of Fintech Solutions | Open-market sale | SELL | $239K 4,500 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 23 | Daggs Nicole JEVP, Human Res & Corp Svcs | Open-market sale · 10b5-1 plan | SELL | $69K 745 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Walsh Mark T.Director, CEO & Director | Option exercise | M | — 93.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 21 | Komasinski MichaelDirector, CEO | Grant or award | A | — 141.7K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 21 | Reed Timothy R.EVP, R&D and Tour | Option exercise | M | — 11.4K sh | Mar 16, 2026 traded Mar 14, 2026 |